Connecting type 1 and type 2 diabetes through innate immunity.
about
Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammationIslet inflammation in plain sightLipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusMinireview: Emerging Concepts in Islet Macrophage Biology in Type 2 DiabetesUse of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin SecretionmicroRNA in the development of diabetic complications.Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes.Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function.TRAIL modulates the immune system and protects against the development of diabetes.Hyperglycemia Impairs Neutrophil-Mediated Bacterial Clearance in Mice Infected with the Lyme Disease PathogenThe inflammation highway: metabolism accelerates inflammatory traffic in obesity.SENP1-mediated NEMO deSUMOylation in adipocytes limits inflammatory responses and type-1 diabetes progressionMeta-immunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression.The role of adipose-derived inflammatory cytokines in type 1 diabetesl-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Lysosomal metal, redox and proton cycles influencing the CysHis cathepsin reaction.Autophagy regulates inflammation following oxidative injury in diabetes.Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation.Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes.ER stress and development of type 1 diabetes.Double-stranded RNA-dependent protein kinase signalling and paradigms of cardiometabolic syndrome.Autoantibodies against PFDN2 are associated with an increased risk of type 2 diabetes: A case-control study.Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.Tumor necrosis factor α-induced protein-3 protects zinc transporter 8 against proinflammatory cytokine-induced downregulation.Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines.Metabolic pressure and the breach of immunological self-tolerance.Antimicrobial peptides as a possible interlink between periodontal diseases and its risk factors: A systematic review.Pediatric Non-Alcoholic Fatty Liver Disease.GADA and anti-ZnT8 complicate the outcome of phenotypic type 2 diabetes of adults.The Relationship between insulin variable number of tandem repeats (INS-VNTR) -23 A/T and cytotoxic Tlymphocyte associated protein-4 (CTLA-4) +49 A/G polymorphisms with islet autoantibodies in persons with diabetes.
P2860
Q26830676-0B13CCEC-FD89-4E1E-817A-71B709D4D917Q27012796-057AC4AE-608A-4444-B155-8A347715A95AQ28080521-45A1BA3D-5F2A-4006-AF59-14F76E32C9A6Q28083768-4770B54A-6BCC-40D1-BE6F-02BA446A25B8Q28551169-BF66F2DF-7788-4213-A17D-92196516B7D5Q30353835-6014E6EB-9B22-4ED9-800B-27D09B56FF26Q30411328-0AD76137-AA2E-46E8-A6C3-61D513D035E4Q33850372-4CC2BB36-AF48-4425-89B4-5C0269DFB56DQ35155962-635CA9B2-081D-4816-8C06-BF6D8986C1CEQ36060840-BBBFF246-E36E-4551-B107-2C2BB8E5078BQ36174974-25B178E1-90D4-4BC3-AF65-981C247F4A86Q36325236-FD3C0DDC-A39A-4F33-8318-B26B84F78830Q37014996-7CAC5C71-E786-4055-8B9A-0FBA81B1C879Q37238016-7D89D6D6-86EA-4CD0-B6F5-A9E35FE09087Q37412089-FBD19430-24E7-4F4A-8061-18EBB9E32A7CQ38072811-D7B50DC6-9677-462A-9F53-CF8719E6371BQ38076252-CFD62EA8-810C-4A90-A039-3E36DF203779Q38099615-B0FCDFB2-75DA-4DD1-868D-33791F7BFB9FQ38267786-3FC34E77-1018-4D9A-9F35-2885AA14324BQ38558319-2A5E3208-1ECA-4946-95AF-4EADB2E5D423Q39043385-2DE05223-A33F-4AF5-B834-0A4797054EEAQ40113555-292FABD2-EBCE-4D71-B004-C2805C4867FBQ40545494-E2743E68-BAC7-4771-AB1D-E70D91E024F1Q41182403-B6BC1AE1-E314-477B-A904-CEDCD1C2C06AQ41915768-6ECF9205-4245-4716-B8A5-CA7417CBF91CQ46439239-1BEC56B9-BE0F-426E-8FBE-297FE3D8EA66Q48224894-091178BD-9292-4B52-AA61-B3D8D8D3C44DQ52979087-FD8BA44A-4575-4D29-B5D1-89C134EFFE9EQ53631548-BBFF1268-0AD8-43A0-AF8D-A508AC60FB28Q55288585-B37D5D6F-AC22-4DE2-909D-23C1A5F22072
P2860
Connecting type 1 and type 2 diabetes through innate immunity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Connecting type 1 and type 2 diabetes through innate immunity.
@en
Connecting type 1 and type 2 diabetes through innate immunity.
@nl
type
label
Connecting type 1 and type 2 diabetes through innate immunity.
@en
Connecting type 1 and type 2 diabetes through innate immunity.
@nl
prefLabel
Connecting type 1 and type 2 diabetes through innate immunity.
@en
Connecting type 1 and type 2 diabetes through innate immunity.
@nl
P2860
P1476
Connecting type 1 and type 2 diabetes through innate immunity.
@en
P2093
Ajay Chawla
Justin I Odegaard
P2860
P304
P356
10.1101/CSHPERSPECT.A007724
P577
2012-03-01T00:00:00Z